Literature DB >> 15943543

Effectiveness of payment for reduced carbon monoxide levels and noncontingent payments on smoking behaviors in cocaine-abusing outpatients wearing nicotine or placebo patches.

Eve J Wiseman1, D K Williams, D E McMillan.   

Abstract

In a 2-week intervention to reduce cigarette smoking among outpatients in treatment for cocaine addiction, 20 subjects were randomly assigned to a contingent group, receiving monetary vouchers for breath samples with carbon monoxide (CO) levels of 8 ppm or less, or to a noncontingent group, receiving vouchers regardless of CO level. Subjects wore either nicotine or placebo patches in a randomized crossover design. Contingent subjects had significantly lower CO levels and met the 8 ppm target significantly more often than did noncontingent subjects; however, number of cigarettes reported smoked did not differ between groups. Use of nicotine patches resulted in CO levels significantly lower than did use of placebo patches, but levels still exceeded 8 ppm regardless of type of patch. Because contingent reward helped cocaine-dependent smokers achieve nonsmoking CO targets, behavioral antismoking interventions merit continued study in similar populations. Copyright 2005 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943543     DOI: 10.1037/1064-1297.13.2.102

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  13 in total

1.  Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.

Authors:  Theresa Winhusen; Maxine Stitzer; George Woody; Gregory Brigham; Frankie Kropp; Udi Ghitza; Robert Lindblad; Bryon Adinoff; Cindy Green; Gaurav Sharma; Eugene Somoza
Journal:  Contemp Clin Trials       Date:  2011-10-08       Impact factor: 2.226

2.  Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement.

Authors:  Jesse Dallery; Bethany R Raiff
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

Review 3.  Contingency Management: New Directions and Remaining Challenges for An Evidence-Based Intervention.

Authors:  Carla J Rash; Maxine Stitzer; Jeremiah Weinstock
Journal:  J Subst Abuse Treat       Date:  2016-09-28

4.  Contingency management in the 21st century: technological innovations to promote smoking cessation.

Authors:  Jesse Dallery; Bethany R Raiff
Journal:  Subst Use Misuse       Date:  2011       Impact factor: 2.164

5.  Contingent vouchers and motivational interviewing for cigarette smokers in residential substance abuse treatment.

Authors:  Damaris J Rohsenow; Jennifer W Tidey; Rosemarie A Martin; Suzanne M Colby; Alan D Sirota; Robert M Swift; Peter M Monti
Journal:  J Subst Abuse Treat       Date:  2015-03-12

Review 6.  The use of financial incentives in promoting smoking cessation.

Authors:  Stacey C Sigmon; Mollie E Patrick
Journal:  Prev Med       Date:  2012-04-16       Impact factor: 4.018

7.  Effects of internet-based voucher reinforcement and a transdermal nicotine patch on cigarette smoking.

Authors:  Irene M Glenn; Jesse Dallery
Journal:  J Appl Behav Anal       Date:  2007

8.  An internet-based abstinence reinforcement smoking cessation intervention in rural smokers.

Authors:  William W Stoops; Jesse Dallery; Nell M Fields; Paul A Nuzzo; Nancy E Schoenberg; Catherine A Martin; Baretta Casey; Conrad J Wong
Journal:  Drug Alcohol Depend       Date:  2009-07-16       Impact factor: 4.492

9.  Treating Smokers in Substance Treatment With Contingent Vouchers, Nicotine Replacement and Brief Advice Adapted for Sobriety Settings.

Authors:  Damaris J Rohsenow; Rosemarie A Martin; Jennifer W Tidey; Suzanne M Colby; Peter M Monti
Journal:  J Subst Abuse Treat       Date:  2016-08-18

10.  Acceptability of an Internet-based contingency management intervention for smoking cessation: views of smokers, nonsmokers, and healthcare professionals.

Authors:  Bethany R Raiff; Brantley P Jarvis; Marissa Turturici; Jesse Dallery
Journal:  Exp Clin Psychopharmacol       Date:  2013-06       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.